Study of Multiple-dose Kukoamine B Mesilate in Sepsis Patients
Clinical trial NCT03237728 · COMPLETED
Trial details
- NCT number
- NCT03237728
- Sponsor
- Tianjin Chasesun Pharmaceutical Co., LTD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-28
- Primary completion
- 2019-09-25
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.